Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15 pathway elicits a synergistic response.
Shakiba Y, Vorobyev PO, Yusubalieva GM, Kochetkov DV, Zajtseva KV, Valikhov MP, Kalsin VA, Zabozlaev FG, Semkina AS, Troitskiy AV, Baklaushev VP, Chumakov PM, Lipatova AV.
Shakiba Y, et al. Among authors: baklaushev vp.
Mol Ther Oncolytics. 2023 May 13;29:158-168. doi: 10.1016/j.omto.2023.05.002. eCollection 2023 Jun 15.
Mol Ther Oncolytics. 2023.
PMID: 37387795
Free PMC article.